All articles tagged with #trumprxgov
Originally Published 22 days ago — by The Washington Post
Several drug companies have agreed to lower their drug prices through 'Most Favored Nation' deals with the Trump administration, following initial hesitation from pharmaceutical executives after President Trump called for voluntary price cuts in May.
Originally Published 3 months ago — by Fortune
Mark Cuban comments on President Trump's new drug platform, TrumpRx.gov, which aims to sell discounted prescription drugs directly to consumers. Cuban sees potential if it can challenge existing pharmacy benefit managers (PBMs), though current market reactions suggest skepticism. The platform partners with Pfizer and could influence drug pricing, but experts doubt it will significantly lower costs for most Americans due to systemic issues with PBMs and insurance-based purchasing.
Originally Published 3 months ago — by NPR
President Trump announced a deal with Pfizer to sell drugs directly to consumers at discounted prices through a new website, TrumpRx.gov, aiming to align U.S. drug prices with those in other developed countries. The initiative includes Pfizer's commitment to offer new drugs at the same price globally and to provide drugs to Medicaid at most-favored-nation prices, though the impact on average consumers and Medicaid beneficiaries remains uncertain. The website is expected to launch in 2026, but critics suggest the measure may be more symbolic than transformative.